XML 65 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating activities:      
Net income (loss) $ 25,711 $ (15,305) $ (33,867)
Adjustments to reconcile net income (loss) to net cash flows provided by (used in) operating activities      
Depreciation 538 1,846 740
Accretion of debt discount and loan costs 320 11,508 4,138
Amortization of intangible assets 6,981 6,981 5,157
(Recovery from) provision for inventory obsolescence 1,870 197 (56)
Impairment loss on equipment 0 0 78
Stock-based compensation expense 9,595 5,416 5,941
Deferred income taxes 0 0 40
Changes in assets and liabilities, net of effect of acquisition:      
Accounts receivable (9,360) (25,163) (4,640)
Inventories (8,001) (6,102) 741
Prepaid expenses and other assets (1,439) (581) 422
Accounts payable and accrued expenses (1,234) 32,275 (2,807)
Net cash flows provided by (used in) operating activities 24,981 11,072 (24,113)
Investing activities:      
Product acquisitions 0 (30,685) (1,951)
Acquisitions of equipment (13) (79) (112)
Net cash flows used in investing activities (13) (30,764) (2,063)
Financing activities:      
Proceeds from exercise of stock options 3,369 2,321 670
Proceeds from issuance of common stock, less underwriters discount 0 48,000 0
Proceeds from issuance of Series B preferred stock 0 0 50,000
Payment on note payable 0 (67,346) 0
Proceeds from notes payable 20,000 59,987 0
Equity finance costs 0 (410) (1,417)
Payment of deferred financing fees (436) 0 (450)
Loss on refinancing of former debt 0 (2,794) 0
Payment on share repurchase (205) 0 0
Net cash flows provided by financing activities 22,728 39,758 48,803
Net change in cash and cash equivalents 47,696 20,066 22,627
Cash and cash equivalents at beginning of year 63,888 43,822 21,195
Cash and cash equivalents at end of year 111,584 63,888 43,822
Cash paid for interest 6,979 6,809 6,053
Cash paid for income taxes $ 250 $ 0 0
Non-cash Financing and Investing Activities:      
Adjustments to additional paid in capital dividends in excess of retained earnings     12,500
Accrued financing expenses     $ 600